Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (16,134,000)	$ (6,026,000)
Adjustments to reconcile net loss to cash used in operating activities:
Change in fair value of common stock warrant liabilities	(8,946,000)	(6,570,000)
Change in fair value of contingent consideration	(210,000)
Offering costs	769,000
Depreciation	929,000	632,000
Amortization of intangible assets	116,000	30,000
Lease amortization	1,276,000	1,048,000
Impairment of intangible asset	3,302,000	0
Impairment of goodwill	1,648,000	0
Loss (Gain) on disposal of equipment	23,000	(8,000)
Loss on disposal of intangible assets	222,000
Net amortization of investment premium		(44,000)
Stock-based compensation	1,541,000	2,042,000
Bed debt expense	76,000
Gain on sale of Verdeca		(8,814,000)
Realized gain on corporate securities	(10,221,000)
Corporate securities received in exchange for license agreement		(4,318,000)
Unrealized gain on corporate securities		(656,000)
Write-down of inventory and prepaid production costs	3,593,000	4,311,000
Loss on extinguishment of warrant liability		635,000
Gain on extinguishment of PPP loan	(1,123,000)
Impairment of property and equipment	1,534,000
Deferred income taxes		(107,000)
Changes in operating assets and liabilities:
Accounts receivable	(40,000)	(1,119,000)
Inventories	(2,383,000)	(9,751,000)
Prepaid expenses and other current assets	56,000	39,000
Other noncurrent assets	(158,000)	(15,000)
Accounts payable and accrued expenses	(372,000)	(580,000)
Amounts due to related parties	(16,000)	40,000
Unearned revenue	(8,000)	(34,000)
Other current liabilities	1,000	(43,000)
Operating lease payments	(1,343,000)	(910,000)
Net cash used in operating activities	(25,868,000)	(30,218,000)
CASH FLOWS FROM INVESTING ACTIVITIES:
Proceeds from sale of property and equipment	19,000	8,000
Purchases of property and equipment	(1,007,000)	(2,335,000)
Proceeds from sale of Verdeca		3,153,000
Acquisitions, net of cash acquired	(4,250,000)	(500,000)
Purchases of investments		(1,292,000)
Proceeds from sales and maturities of investments	21,846,000	18,250,000
Net cash provided by (used in) investing activities	16,608,000	17,284,000
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from borrowings		3,108,000
Payments of transaction costs relating to extinguishment of warrant liability		(863,000)
Principal payments on notes payable	(2,146,000)	(34,000)
Proceeds from exercise of warrants	22,000	9,372,000
Proceeds from exercise of stock options and purchases through ESPP	39,000	51,000
Capital contributions received from non-controlling interest	750,000	1,578,000
Net cash provided by financing activities	21,900,000	20,560,000
Effects of foreign currency translation on cash and cash equivalents	2,000
Net increase (decrease) in cash, cash equivalents and restricted cash	12,642,000	7,626,000
Cash, cash equivalents and restricted cash — beginning of period	16,043,000	8,417,000
Cash, cash equivalents and restricted cash — end of period	28,685,000	16,043,000
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:
Cash paid for interest	25,000	10,000
Cash paid for taxes	1,000	1,000
NONCASH TRANSACTIONS:
Right of use assets obtained in exchange for new operating lease liabilities	1,664,000	331,000
Right of use assets obtained through modification of existing lease agreement		4,207,000
Fixed assets acquired with notes payable		37,000
Purchases of fixed assets included in accounts payable and accrued expenses		71,000
Arcadia Wellness [Member]
NONCASH TRANSACTIONS:
Shares of common stock issued at closing of ISI transaction	2,053,000
Industrial Seed Innovations [Member]
Adjustments to reconcile net loss to cash used in operating activities:
Change in fair value of contingent consideration	(210,000)
NONCASH TRANSACTIONS:
Shares of common stock issued at closing of ISI transaction		432,000
December 2020 Purchase Agreement [Member]
NONCASH TRANSACTIONS:
Common stock warrants issued to placement agent and included in offering costs related to purchase agreement		287,000
January 2021 PIPE Purchase Agreement [Member]
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock and warrants from Offering	25,147,000
Payments of offering costs	(1,912,000)
NONCASH TRANSACTIONS:
Common stock warrants issued to placement agent and included in offering costs related to purchase agreement	$ 942,000
December 2020 Offering [Member]
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock and warrants from Offering		8,000,000
Payments of offering costs		(652,000)
May 2020 Warrants Transaction [Member]
NONCASH TRANSACTIONS:
Common stock warrants issued to placement agent and included in offering costs		215,000
July 2020 Warrants Transaction [Member]
NONCASH TRANSACTIONS:
Common stock warrants issued to placement agent and included in offering costs		$ 101,000